Supplementary Materials from Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer

Authors :: Gregory B. Lesinski
Tanios Bekaii-Saab
Miguel Villalona-Calero
Anne M. Noonan
Daniel Ahn
Sanaa Tahiri
Kristen Ciombor
Christina Wu
Sameh Mikhail
Susan Geyer
Thomas A. Mace
Matthew R. Farren
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Table S1. Antibodies used for flow cytometry Table S2. Monte Carlo cross-validation of continuous measure markers. Table S3. Monte Carlo cross-validation of dichotomous measure markers. Table S4. Pancreatic cancer patient circulating immune cell frequencies Figure S1. Overall survival does not predict plasma MCP-1 levels

Full Text Access

Tools